This bill requires a provider to remain on-site and available, but not in the room with a patient when ketamine is administered for nonanesthetic indications.
The task force concluded, following months of study, that MDMA and psilocybin (“magic mushrooms”) can offer significant benefits to those with mental illness.
Following months of study, the Utah Mental Illness and Psychotherapy Task Force found that MDMA and psilocybin (“magic mushrooms”) can offer significant benefits to those with mental illness.
Drug policy, like all policy, should be based on facts. In this case, the facts show that psychotherapeutics are safer and less harmful than alcohol and not deserving of their Schedule I classification.
